124 related articles for article (PubMed ID: 28059830)
21. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
22. Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma.
Kohga K; Takehara T; Tatsumi T; Miyagi T; Ishida H; Ohkawa K; Kanto T; Hiramatsu N; Hayashi N
Cancer Res; 2009 Oct; 69(20):8050-7. PubMed ID: 19826051
[TBL] [Abstract][Full Text] [Related]
23. ADAM10 correlates with uveal melanoma metastasis and promotes in vitro invasion.
Gangemi R; Amaro A; Gino A; Barisione G; Fabbi M; Pfeffer U; Brizzolara A; Queirolo P; Salvi S; Boccardo S; Gualco M; Spagnolo F; Jager MJ; Mosci C; Rossello A; Ferrini S
Pigment Cell Melanoma Res; 2014 Nov; 27(6):1138-48. PubMed ID: 25124714
[TBL] [Abstract][Full Text] [Related]
24. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
Lee SC; Kim OH; Lee SK; Kim SJ
Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
[TBL] [Abstract][Full Text] [Related]
25. ADAM10 and ADAM17 have opposite roles during sprouting angiogenesis.
Caolo V; Swennen G; Chalaris A; Wagenaar A; Verbruggen S; Rose-John S; Molin DG; Vooijs M; Post MJ
Angiogenesis; 2015 Jan; 18(1):13-22. PubMed ID: 25218057
[TBL] [Abstract][Full Text] [Related]
26. Role of ADAM10 and ADAM17 in CD16b shedding mediated by different stimulators.
Guo S; Peng M; Zhao Q; Zhang W
Chin Med Sci J; 2012 Jun; 27(2):73-9. PubMed ID: 22770404
[TBL] [Abstract][Full Text] [Related]
27. Melatonin stimulates the nonamyloidogenic processing of βAPP through the positive transcriptional regulation of ADAM10 and ADAM17.
Shukla M; Htoo HH; Wintachai P; Hernandez JF; Dubois C; Postina R; Xu H; Checler F; Smith DR; Govitrapong P; Vincent B
J Pineal Res; 2015 Mar; 58(2):151-65. PubMed ID: 25491598
[TBL] [Abstract][Full Text] [Related]
28. GLUT5 regulation by AKT1/3-miR-125b-5p downregulation induces migratory activity and drug resistance in TLR-modified colorectal cancer cells.
Park GB; Jeong JY; Kim D
Carcinogenesis; 2020 Oct; 41(10):1329-1340. PubMed ID: 32649737
[TBL] [Abstract][Full Text] [Related]
29. Identification of ADAM10 as a major TNF sheddase in ADAM17-deficient fibroblasts.
Mezyk-Kopeć R; Bzowska M; Stalińska K; Chełmicki T; Podkalicki M; Jucha J; Kowalczyk K; Mak P; Bereta J
Cytokine; 2009 Jun; 46(3):309-15. PubMed ID: 19346138
[TBL] [Abstract][Full Text] [Related]
30. miR-448 suppressed gastric cancer proliferation and invasion by regulating ADAM10.
Wu X; Tang H; Liu G; Wang H; Shu J; Sun F
Tumour Biol; 2016 Aug; 37(8):10545-51. PubMed ID: 26852749
[TBL] [Abstract][Full Text] [Related]
31. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
Chen J; Yuan W; Wu L; Tang Q; Xia Q; Ji J; Liu Z; Ma Z; Zhou Z; Cheng Y; Shu X
Oncotarget; 2017 Feb; 8(6):9961-9973. PubMed ID: 28035069
[TBL] [Abstract][Full Text] [Related]
32. The transcription factor PAX2 regulates ADAM10 expression in renal cell carcinoma.
Doberstein K; Pfeilschifter J; Gutwein P
Carcinogenesis; 2011 Nov; 32(11):1713-23. PubMed ID: 21880579
[TBL] [Abstract][Full Text] [Related]
33. Expression profile of ADAM10 and ADAM17 in allergic rhinitis.
Chueh HW; Park SK; Hur DY; Bae WY
Int Forum Allergy Rhinol; 2015 Nov; 5(11):1036-41. PubMed ID: 26250527
[TBL] [Abstract][Full Text] [Related]
34. ADAM17 co-purifies with TIMP-3 and modulates endothelial invasion responses in three-dimensional collagen matrices.
Kwak HI; Mendoza EA; Bayless KJ
Matrix Biol; 2009 Oct; 28(8):470-9. PubMed ID: 19666115
[TBL] [Abstract][Full Text] [Related]
35. The disintegrin-metalloproteinases ADAM 10, 12 and 17 are upregulated in invading peripheral tumor cells of basal cell carcinomas.
Oh ST; Schramme A; Stark A; Tilgen W; Gutwein P; Reichrath J
J Cutan Pathol; 2009 Apr; 36(4):395-401. PubMed ID: 19278423
[TBL] [Abstract][Full Text] [Related]
36. Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines.
Yang AD; Fan F; Camp ER; van Buren G; Liu W; Somcio R; Gray MJ; Cheng H; Hoff PM; Ellis LM
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4147-53. PubMed ID: 16857785
[TBL] [Abstract][Full Text] [Related]
37. HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells.
Ji M; Lee EJ; Kim KB; Kim Y; Sung R; Lee SJ; Kim DS; Park SM
Oncol Rep; 2015 May; 33(5):2299-308. PubMed ID: 25813246
[TBL] [Abstract][Full Text] [Related]
38. PKM2 Subcellular Localization Is Involved in Oxaliplatin Resistance Acquisition in HT29 Human Colorectal Cancer Cell Lines.
Ginés A; Bystrup S; Ruiz de Porras V; Guardia C; Musulén E; Martínez-Cardús A; Manzano JL; Layos L; Abad A; Martínez-Balibrea E
PLoS One; 2015; 10(5):e0123830. PubMed ID: 25955657
[TBL] [Abstract][Full Text] [Related]
39. Proteolytically active ADAM10 and ADAM17 carried on membrane microvesicles in human abdominal aortic aneurysms.
Folkesson M; Li C; Frebelius S; Swedenborg J; Wågsäter D; Williams KJ; Eriksson P; Roy J; Liu ML
Thromb Haemost; 2015 Nov; 114(6):1165-74. PubMed ID: 26422658
[TBL] [Abstract][Full Text] [Related]
40. Regorafenib (Stivarga) pharmacologically targets epithelial-mesenchymal transition in colorectal cancer.
Fan LC; Teng HW; Shiau CW; Tai WT; Hung MH; Yang SH; Jiang JK; Chen KF
Oncotarget; 2016 Sep; 7(39):64136-64147. PubMed ID: 27580057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]